Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2010
09/30/2010US20100247669 Polymer-agent conjugates, particles, compositions, and related methods of use
09/30/2010US20100247668 Polymer-agent conjugates, particles, compositions, and related methods of use
09/30/2010US20100247667 Material for soft tissue enlargement
09/30/2010US20100247666 Method for Preparing Suspensions of Low-Solubility Materials
09/30/2010US20100247665 Spherical Particle and Method for Producing the Same
09/30/2010US20100247664 Method of preventing or treating metabolic syndrome
09/30/2010US20100247663 Microspheres
09/30/2010US20100247662 Biologic Modulations with Nanoparticles
09/30/2010US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
09/30/2010US20100247659 Phenylphthalimide analogs for treating diabetic macular edema
09/30/2010US20100247658 Organic compounds
09/30/2010US20100247657 Telomerase reverse transcriptase variant
09/30/2010US20100247656 Method for in situ Generation of Molecular Iodine on Mucus Membranes Using Nanoparticles
09/30/2010US20100247655 Synthesis of Small Particles
09/30/2010US20100247654 Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer
09/30/2010US20100247653 Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
09/30/2010US20100247652 Alginate Biomaterials for the Treatment of Hepatic Disorders
09/30/2010US20100247651 Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
09/30/2010US20100247650 Treatment for pre-eclampsia in pregnant women using targeted apheresis
09/30/2010US20100247649 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
09/30/2010US20100247648 Antimicrobial compounds
09/30/2010US20100247647 Sustained release tablets with hydromorphone
09/30/2010US20100247646 Extended release tablets of nisoldipine
09/30/2010US20100247645 Pharmaceutical combination of aliskiren and valsartan
09/30/2010US20100247644 Adhesive compositions for the treatment of xerostomia
09/30/2010US20100247643 Oral formulations
09/30/2010US20100247642 Stable pharmaceutical formulation for a dpp-iv inhibitor
09/30/2010US20100247641 Mechanical protective layer for solid dosage forms
09/30/2010US20100247640 Solid Oral Dosage Form Containing An Enhancer
09/30/2010US20100247639 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
09/30/2010US20100247638 organoleptically improved dietary fiber composition and a process thereof (teestar)
09/30/2010US20100247637 Compositions and pharmaceutical forms for the oral administration of thyroid hormones able to combat the action of sequestrants in the gastrointestinal tract
09/30/2010US20100247636 Nanoparticulate and controlled release compositions comprising nilvadipine
09/30/2010US20100247635 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
09/30/2010US20100247634 Compositions and Methods for Inhibiting Gastric Acid Secretion
09/30/2010US20100247633 Polypeptide Films and Methods
09/30/2010US20100247632 Stabilized solubility-enhanced formulations for oral delivery
09/30/2010US20100247631 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
09/30/2010US20100247629 Method for drug loading in liposomes
09/30/2010US20100247628 Skin Treatment Compositions Containing Copper-Pigment Complexes
09/30/2010US20100247627 Foxn1 and pigmentation
09/30/2010US20100247626 Pegylated compounds for age-related macular degeneration
09/30/2010US20100247625 Orally Bioavailable Lipid-Based Constructs
09/30/2010US20100247624 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
09/30/2010US20100247623 Cancer Stem Cell Vaccine
09/30/2010US20100247622 Treatment regime for proliferative disorders
09/30/2010US20100247621 Codon modified immunogenic compositions and methods of use
09/30/2010US20100247620 Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product
09/30/2010US20100247619 Nanostructured Lipid Carriers Containing Riluzole And Phamaceutical Formulations Containing Said Particles
09/30/2010US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
09/30/2010US20100247617 Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)yl)-4-Penten-2-Amine
09/30/2010US20100247616 Patch and patch preparation
09/30/2010US20100247612 Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same
09/30/2010US20100247611 Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
09/30/2010US20100247610 Gastric retained gabapentin dosage form
09/30/2010US20100247609 Pharmaceutical compositions
09/30/2010US20100247608 Pharmaceutical compositions comprising hgh for oral delivery
09/30/2010US20100247606 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010US20100247604 Method of treatment of connective tissues and organs and uses of said tissues and organs
09/30/2010US20100247602 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
09/30/2010US20100247601 Repair and treatment of bone defect using cells induced by agent produced by chondrocytes capable of hypertrophication and scaffold
09/30/2010US20100247600 Therapeutic drug eluting implant cover and method of making the same
09/30/2010US20100247599 Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
09/30/2010US20100247593 Novel compounds and pharmaceutical preparations
09/30/2010US20100247591 Skin Treatment Compositions Containing Copper-Pigment Complexes
09/30/2010US20100247590 Peptide-Based Systems For Delivery Of Cosmetic Agents
09/30/2010US20100247587 Pigmentation-regulating compounds
09/30/2010US20100247586 Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
09/30/2010US20100247585 Stabilized pharmaceutical product
09/30/2010US20100247584 Compositions useful for treating gastroesophageal reflux disease
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010US20100247582 Method of preparing fibre-containing pectin product and pectin products hereof
09/30/2010US20100247453 Composition and method of treating a sore throat
09/30/2010US20100247452 Use of erythropoietin
09/30/2010US20100247451 Use of erythropoietin
09/30/2010US20100247450 Use of erythropoietin
09/30/2010US20100247449 Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010US20100247436 In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
09/30/2010DE102009013012A1 Mit Therapeutika und Diagnostika beladene Kompositmaterialien umfassend Polymernanopartikel und Polymerfasern With therapeutics and diagnostics loaded composite materials comprising polymer nanoparticles and polymer fibers
09/30/2010CA2757026A1 Cholesterol level lowering liposomes
09/30/2010CA2756941A1 Compositions and methods for treatment of hemorrhage
09/30/2010CA2756883A1 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
09/30/2010CA2756669A1 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
09/30/2010CA2756636A1 Compositions and methods for preferential distribution of active agents to injury sites
09/30/2010CA2756581A1 Ascorbate-linked nanosystems for brain delivery
09/30/2010CA2756499A1 Pharmaceutical composition containing a drug and sirna
09/30/2010CA2756222A1 Transdermal delivery
09/30/2010CA2756181A1 Carrier
09/30/2010CA2756170A1 Glycoconjugate vaccines
09/30/2010CA2756065A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010CA2756000A1 Method for preparing suspensions of low-solubility materials
09/30/2010CA2755976A1 Methods of treatment using combination therapy
09/30/2010CA2755692A1 Solid preparation
09/30/2010CA2755687A1 Anti-adhesive composition, solid preparation, and process for producing the same
09/30/2010CA2755383A1 Solid preparation
09/30/2010CA2754691A1 Dry powder formulations and methods for treating pulmonary diseases
09/30/2010CA2754684A1 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
09/30/2010CA2754680A1 Pharmaceutical formulations and methods for treating respiratory tract infections
09/30/2010CA2754677A1 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
1 ... 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 ... 2991